# Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season

> **NCT01649713** · PHASE4 · COMPLETED · sponsor: **Fluart Innovative Vaccine Ltd, Hungary** · enrollment: 120 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Fluval AB vaccination

## Key facts

- **NCT ID:** NCT01649713
- **Lead sponsor:** Fluart Innovative Vaccine Ltd, Hungary
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2012-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01649713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01649713, "Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination Season". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01649713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*